Country: Singapore
Language: English
Source: HSA (Health Sciences Authority)
TERBUTALINE SULPHATE
ASTRAZENECA SINGAPORE PTE LTD
R03AC03
0.5 mg/dose
POWDER, METERED
RESPIRATORY (INHALATION)
Prescription Only
AstraZeneca Dunkerque Production
1989-05-12
1 07/ AB/ SG/ RITA.000-429-468.2.0 BRICANYL TURBUHALER 0.5 MG/ DOSE _terbutaline sulphate _ INHALATION POW DER COMPOSITION Each metered dose contains: Terbutaline sulphate 0.5 mg. PHARMACEUTICAL FORM Inhalation powder. INDICATIONS Bronchial asthma. Chronic bronchitis, emphysema and other lung diseases where bronchospasm is a complicating factor. DOSAGE AND METHOD OF ADMINISTRATION The dosage of inhaled terbutaline via Bricanyl Turbuhaler should be individualized. Bricanyl Turbuhaler should be used as required rather than regularly. _A dults and children ov er 12 years:_ 0.50 mg as required. In severe cases the single dose may be increased to 1.5 mg. The total dose in 24 hours should not exceed 6 mg. _Children 3-12 years:_ 0.50 mg as required. In severe cases the single dose may be increased to 1 mg. The total dose in 24 hours should not exceed 4 mg. When prescribing Bricanyl Turbuhaler to young children it is necessary to ascertain that they can follow the instructions for use. INSTRUCTION FOR CORRECT USE OF TURBUHALER Bricanyl Turbuhaler inhalation pow d er 0.5 mg/ d ose 2 Turbuhaler is inspiratory flow -driven which means that, when the patient inhales through the mouthpiece, the substance will follow the inspired air into the airways. N OTE It is important to instruct the patient to carefully read the instructions for use at the end of this leaflet to breathe in forcefully and deeply through the mouthpiece to ensure that an optimal dose is delivered to the lungs never to breathe out through the mouthpiece The patient may not taste or feel any medication when using Turbuhaler due to the small amount of drug dispensed. For Read the complete document